You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
滿貫集團(03390.HK)首次將內地中成藥引入香港及澳門市場
阿思達克 09-19 13:31
滿貫集團(03390.HK)宣布,與高和醫藥及濟人藥業達成合作,取得該公司旗下中成藥產品——港版疏風解毒膠囊「葯信」的香港及澳門獨家代理權,成為滿貫第一隻從內地引入香港及澳門市場的中成藥品牌。 疏風解毒膠囊「葯信」主要針對Omicron的呼吸道感染癥狀,藥性溫和有效,相對較少腹脹、肚瀉、腸胃不適等副作用,適合輕症及體弱人群。連續六次被國家衛生健康委和國家中醫藥管理局列為新型冠狀疾病推薦用藥。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account